Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenue:
Net product sales		$ 34	$ 583	$ 35
Licensing and other revenue	871	241	7,131	702
Total revenue	871	275	7,714	737
Costs and expenses:
Costs of goods sold		51	396	411
Selling, general and administrative	852	1,977	3,667	5,413
Research and development	1,104	2,617	3,363	6,292
Total costs and expenses	1,956	4,645	7,426	12,116
Income (loss) from operations	(1,085)	(4,370)	288	(11,379)
Other income (expense):
Interest income		4	3	10
Foreign exchange gain (loss)	207	(621)	(57)	38
Warrant amendment expense			(936)
Interest expense (see Note 3)	(254)	(409)	(997)	(870)
Other expense, net	(47)	(1,026)	(1,987)	(822)
Loss before income taxes	(1,132)	(5,396)	(1,699)	(12,201)
Income tax expense		(1)	(2)	(4)
Net loss	(1,132)	(5,397)	(1,701)	(12,205)
Deemed dividends on convertible preferred stock	(1,624)		(3,550)
Loss attributable to common stockholders	(2,756)	(5,397)	(5,251)	(12,205)
Basic and diluted loss per common share (in Dollars per share)	$ (0.03)	$ (0.08)	$ (0.06)	$ (0.18)
Weighted average common shares outstanding (in Shares)	84,618,394	71,003,667	81,826,154	67,406,765
Net loss	(1,132)	(5,397)	(1,701)	(12,205)
Deemed dividends on convertible preferred stock	(1,624)		(3,550)
Other comprehensive income (loss), net of income tax expense:
Foreign currency translation adjustments	(210)	616	47	(83)
Other comprehensive income (loss), net of $0 income tax expense	(210)	(616)	47	(83)
Comprehensive loss	$ (1,342)	$ (4,781)	$ (1,654)	$ (12,288)